Cyclin-dependent kinases: Biological functions and involvement in human pathology;KINASES DEPENDANTES DES CYCLINES: ROLE BIOLOGIQUE AT IMPLICATIONS DANS LA PATHOLOGIE HUMAINE

Medecine/Sciences

Volumn 12, Issue 2, 1996, Pages 165-173

  Wolowiec, Dariusz ^a,b   Ffrench, Martine ^c,d  

^a Hospitalo Universitaire   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c Hospitalier   (France)

^d UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; HISTONE H1; PROTEIN SUBUNIT; TRANSCRIPTION FACTOR; VIRUS T ANTIGEN;

ALZHEIMER DISEASE; ARTICLE; BRAIN METABOLISM; CARCINOGENESIS; CELL CYCLE; CELL DEATH; CELL TRANSFORMATION; DEPHOSPHORYLATION; EUKARYOTIC CELL; HUMAN; HUMAN CELL; MITOSIS; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; TUMOR SUPPRESSOR GENE; VIRUS ONCOGENE; WART VIRUS;

ADENOVIRIDAE; EUKARYOTA; HUMAN PAPILLOMA VIRUS; HUMAN PAPILLOMAVIRUS TYPES; SIMIAE; SIMIAN VIRUS; SIMIAN VIRUS 40;

EID: 0030068001     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/707     Document Type: Article

References (58)

1. Sherr CJ. Mammalian G1 cyclins Cell 1993; 73: 1059-65.
2. Lamas E, Zindy F, Sobczack J, Paterlini P, Wang J, Chenivesse X, Henglein B, Bréchot C Cycline-A et cancer, médecine/sciences 1993; 9: 676-83.
3. Bai C, Richman R, Elledge SJ. Human cyclin F. EMBO J 1994; 13: 6087-98.
4. Okamoto K, Beach D. Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J 1994; 13: 4816-22.
5. Fisher RP, Morgan DO. A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell 1994; 78: 713-24.
6. +. Cell 1987; 50: 319-25.
7. Lee MG, Nurse P. Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2. Nature 1907; 327: 31-5.
8. Draetta G, Beach D. Activation of Cdc2 protein kinase during mitosis in human cells: cell cycle-dependent phosphorylation and subunit rearrangement. Cell 1988; 54: 17-26
9. Wolowiec D, Deviller P, Simonin D, Souchier C, Rimokh R, Benchaib M, Bryon PA, Ffrench M. Cdkl is a marker of proliferation in human Ivmphoid cells. Int J Cancer 1995; 61: 381-8.
10. King RW, Jackson PK, Kirschner MW. Mitosis in transition. Cell 1994; 79: 563-71.
11. O'Connor PM, Ferris DK, Pagano M, Draetta G, Pines J, Hunter T, Longo DL, Kohn KW. G2 delay induced by nitrogen mustard in human cells affects cyclin A/Cdk2 and cyclin B1/cdc2-kinase complexes differently. J Biol Chem 1993; 268: 8298-308.
12. Darbon J, Fesquet D, Cavadore J. De nouveaux régulateurs du cycle cellulaire: les protéines modulatrices des complexes Cdk-cyclines. médecine/sciences 1995; 11: 349-56.
13. Xiong Y, Zhang H, Beach D. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 1992; 71: 505-14.
14. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75: 805-16.
15. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF1, a potential mediator of p53 tumor supression. Cell 1993; 75: 817-25.
16. kep1, a cyclin-Cdk inhibitor, links transforming growth factorβ- and contact inhibition to cell cycle arrest. Genes Dev 1994; 8: 9-22.
17. kep1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994; 78: 59-66.
18. Meyerson M, Enders GH, Wu CL, Su LK, Gorka C, Nelson C, Harlow E, Tsai LH. A family of human cdc2-related protein kinases. EMBO J 1992; 11: 2909-17.
19. Paris J, Le Guellec R, Couturier A, Le Guellec K, Omilli F, Camonis J, Mac Neill S, Philippe M. Cloning by differential screening of a Xenopus cDNA coding for a protein homologous to cdc2. Proc Natl Acad Sci USA 1991; 88: 1039-43.
20. Demetrick DJ, Zhang H, Beach DH. Chromosomal mapping of human CDK2, CDK4 and CDK5 cell cycle kinase genes. Cytogenet Cell Genet 1994; 66: 72-4.
21. Pines J, Hunter T. Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B. Nature 1990; 346: 760-3.
22. Koff A, Giordano A, Desai D, Yamashita K, Harper JW, Elledge S, Nishimoto T, Morgan DO, Franza BR, Roberts JM. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle, Science 1992; 257: 1689-94.
23. Tsai LH, Lees E, Faha B, Harlow E, Riabowol K. The cdk2 kinase is required for the G1-to-S transition in mammalian cells. Oncogene 1993; 8: 1593-602.
24. Lees E, Faha B, Dulic V, Reed SI, Harlow E. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev 1992; 6: 1874-85.
25. Xu M, Sheppard KA, Peng CY, Yee AS, Piwnica-Worms H. Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation. Mol Cell Biol 1994; 14: 8420-31.
26. van den Heuvel S, Harlow E. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 1993; 262: 2050-4.
27. PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell 1992; 71: 323-34.
28. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato JY. D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol 1994; 14: 2066-76.
29. Lukas J, Bartkova J, Rohde M, Strauss M, Bartek J. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol Cell Biol 1995; 15: 2600-11.
30. Horton LE, Quiang Y, Templeton DJ, G1 cyclins control the retinoblastoma gene product growth regulation activity via up-stream mechanisms. Cell Growth Different 1995; 6: 395-407.
31. Meyerson M, Harlow E. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol 1994; 14: 2077-86.
32. Suzuki-Takahashi I, Kitagawa M, Saijo M, Higashi H, Ogino H, Matsumoto H, Taya Y, Nishimura S, Okuyama A. The interactions of E2F with pRB and with p107 are regulated via the phosphorylation of pRB by a cyclin-dependent kinase. Oncogene 1995; 10: 1691-8.
33. Bates S, Parry D, Bonetta L, Vousden K, Dickson C, Peters G. Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein. Oncogene 1994; 9: 1633-40.
34. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cvclin D/CDK4. Nature 1993; 366: 704-7.
35. INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 1994; 371: 257-61.
36. Li Y, Nichols MA, Shay JW, Xiong Y. Transcriptional repression of the D-type cyclin dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res 1994; 54: 6078-82.
37. Lew J, Huang QQ, Qi Z, Winkfein RJ, Aebersold R, Hunt T, Wang JH. A brain-specific activator of cyclin-dependent kinase 5. Nature 1994; 371 : 423-6.
38. Tsai LH, Takahashi T, Caviness Jr VS, Harlow E. Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development 1993; 119: 1029-40.
39. Baumann K, Mandelkow EM, Biernat J, Piwnica-Worms H, Mandelkow E. Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5. FEBS Lett 1993; 336: 417-24.
40. INK4B/MTS2 - related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev 1994; 8: 2939-52.
41. MO15 catalytic subunit of cdk-activating kinase. Oncogene 1994; 9: 3127-38.
42. Roy R, Bergmann E, Egly J. TFIIH (BTF2), à l'interface de trois processus cellulaires: transcription, réparation et cycle cellulaire, médicine/sciences 1995; 11: 879-82.
43. Xiang J, Lahti JM, Grenet J, Easton J, Kidd VJ. Molecular cloning and expression of alternatively spliced PITSLRE protein kinase isoforms. J Biol Chem 1994; 269: 15786-94.
44. Lahti JM, Valentine M, Xiang J, Jones B, Amann J, GrenetJ, Richmond G, Look AT, Kidd VJ. Alterations in the PITSLRE protein kinase gene complex on chromosome 1p36 in childhood neuroblastoma. Nature Genet 1994; 7: 370-5.
45. Bunnell BA, Heath LS, Adams DE, Lahti JM, Kidd VJ. Increased expression of a 58-kDa protein Kinase leads to changes in the CHO cell cycle. Proc Natl Acad Sci USA 1990; 87: 7467-71.
46. Lahti JM, Xiang T, Heath LS, Campana D, Kidd VJ. PITSLRE protein kinase activity is associated with apoptosis. Mol Cell Biol 1995; 15: 1-11.
47. rdi2 and cyclin A levels by SV-40 large T antigen. Oncogene 1993; 8: 2987-93.
48. Steinmann KE, Pei XF, Stoeppler H, Schlegel R. Elevated expression and activity of mitotic regulatory proteins in human papillomavirus-immortalized keratinocytes. Oncogene 1994; 9: 387-94.
49. cdr2 and its kinase activity in human gastric and colonic carcinomas. Int J Cancer 1993; 53: 36-41.
50. Keyomarsi K, Pardee AB. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA 1993; 90: 1112-6.
51. Furukawa Y, Terui Y, Sakoe K, Ohta M, Kitagawa S, Miura Y, Saito M. Over-expression and amplification of the CDC2 gene in leukaemia cells. Br J Haematol 1995; 90: 94-9.
52. Khatib ZA, Matsushime H, Valentine M, Shapiro DN, Sherr CJ, Look AT. Coamplification of the CDK4 gene with MDM2 and GZI in human sarcomas. Cancer Res 1993; 53 : 5535-41.
53. Reifenberger G, Reifenberger J, Ichimura K, Meltzer PS, Collins VP. Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. Cancer Res 1994; 54; 4299-303.
54. Schmidt EE, Ichimura K, Reifenberger G, Collins VP. CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res 1994; 54: 6321-4.
55. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994; 368: 753-6.
56. Kamb A, Gruis NA, Weaver-Feldhaus J, Lin Q, Harshman K, Tavtigian SV, Stockert E, Day III RS, Johnson BE, Skolnick MH. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264: 436-40.
57. INK4B) display frequent homozygotous deletions in primary cells from T-but not from B-cell lineage acute lymphoblastic leukemias. Blood 1994; 84: 4038-44.
58. Chedid M, Michieli P, Lengel C. Huppi K, Givol D. A single nucleotide substitution at codon 31 (Ser/Arg) defines a polymorphism in a highly conserved region of the p53-inducible sene WAF1/CIP1. Oncogene 1994; 9: 3021-4.